Arochi & Lindner, SC

With offices in Madrid and México City as well as established corporate, dispute resolution and regulatory practices, well-known IP firm Arochi & Lindner, SC is well placed to offer services in the life sciences sector. The practice offers comprehensive, interdisciplinary legal advice to a full spectrum of life-science clients (from pharma, biotech, medical devices and diagnostics through to health care, vaccines, food, agriculture and cosmetics) throughout the product life cycle, from trade mark and patent prosecution, through registrations, licensing and collaboration agreements, to labelling, advertising and marketing. The practice also handles IP litigation and matters before/with COFEPRIS; and has particular experience in government procurement litigation in cases of conflicting interest among participants. Name partner and practice head Heidi Lindner has over 35 years’ IP experience and is one of the market’s foremost patent litigators in relation to life-science matters related to the pharma, biotech and medical device segments. A counsel to the Mexican Association of Generic Drug Companies, Lindner’s practice also takes in licensing and advisory on life sciences regulatory matters. Key associate support comes from the experienced Celmira Sanchez, whose practice focuses primarily on health regulation; and the equally experienced Manuel Morante whose practice is centred on IP litigation (particularly strategic matters), patents and life sciences. On the administrative litigation front the team can call on the experience of Alberto Santos; and more broadly, the practice also draws on strong non-legal associate specialist support including chemists Francisco Alvarez, Marcos Juarez and Georgina Pimentela; and biological and pharmaceutical chemists Mauricio Caballero and Juan Luis Espinosa. Since research concluded, the team has been considerably strengthened with the hire of dedicated life sciences and compliance practitioner Julio Copo Terrés (who has ‘an integral vision of the sector’, according to peers), as of counsel – effective as of October 2023.